Ignite Creation Date:
2024-05-06 @ 7:48 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02601937
Status:
COMPLETED
Last Update Posted:
2021-12-27
First Post:
2015-10-21
Brief Title:
EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Sponsor:
Epizyme Inc
Organization:
Epizyme Inc
Organization Data
Organization:
Epizyme Inc
Class:
INDUSTRY
Study ID:
EZH-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Epizyme Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None